Press Release
February 21, 2017
Amphastar Announces the Receipt of a CRL for Intranasal Naloxone for the Emergency Treatment of Opioid Overdose
More
December 27, 2016
Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene® Mist
More
November 28, 2016
Amphastar Pharmaceuticals to Present at the 2016 Piper Jaffray Healthcare Conference
More
November 8, 2016
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2016
More
October 28, 2016
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2016
More
September 1, 2016
Amphastar Pharmaceuticals to Present at the 2016 Wells Fargo Healthcare Conference
More
August 8, 2016
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2016
More
August 4, 2016
Amphastar Pharmaceuticals, Inc. Purchases International Medication Systems (UK) Limited from UCB PHARMA GmbH
More
August 1, 2016
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2016
More
June 3, 2016